ARIXTRA
Google image searchProduct monograph
Active ingredient
fondaparinux sodium, 7.5 MG/0.6 ML
DIN: 02258056
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: 0.6ML SINGLE USE PRE-FILLED SYRINGE
Schedule: Prescription
Company: ASPEN PHARMACARE CANADA INC.
Date: 17-JUL-2018
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AX — Other antithrombotic agents (ATC, ATC/DDD)
- B01AX05 — FONDAPARINUX (ATC/DDD)
Reference brand drug: Arixtra
